- Home
- EVAX vs ZOOZ Comparison
EVAX vs ZOOZ Comparison
Compare EVAX & ZOOZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- ZOOZ
- Stock Information
- Founded
- EVAX 2008
- ZOOZ 2013
- Country
- EVAX Denmark
- ZOOZ Israel
- Employees
- EVAX N/A
- ZOOZ 38
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- ZOOZ
- Sector
- EVAX Health Care
- ZOOZ
- Exchange
- EVAX Nasdaq
- ZOOZ NYSE
- Market Cap
- EVAX 16.3M
- ZOOZ 18.8M
- IPO Year
- EVAX 2021
- ZOOZ N/A
- Fundamental
- Price
- EVAX $1.49
- ZOOZ $1.69
- Analyst Decision
- EVAX Strong Buy
- ZOOZ Strong Buy
- Analyst Count
- EVAX 2
- ZOOZ 2
- Target Price
- EVAX $10.00
- ZOOZ $5.00
- AVG Volume (30 Days)
- EVAX 76.2K
- ZOOZ 40.1K
- Earning Date
- EVAX 05-27-2025
- ZOOZ 05-16-2025
- Dividend Yield
- EVAX N/A
- ZOOZ N/A
- EPS Growth
- EVAX N/A
- ZOOZ N/A
- EPS
- EVAX N/A
- ZOOZ N/A
- Revenue
- EVAX $3,344,000.00
- ZOOZ $1,041,000.00
- Revenue This Year
- EVAX $102.45
- ZOOZ $76.37
- Revenue Next Year
- EVAX $100.30
- ZOOZ $119.44
- P/E Ratio
- EVAX N/A
- ZOOZ N/A
- Revenue Growth
- EVAX 4480.82
- ZOOZ 36.26
- 52 Week Low
- EVAX $1.20
- ZOOZ $1.25
- 52 Week High
- EVAX $21.80
- ZOOZ $3.42
- Technical
- Relative Strength Index (RSI)
- EVAX 43.19
- ZOOZ N/A
- Support Level
- EVAX $1.20
- ZOOZ N/A
- Resistance Level
- EVAX $1.46
- ZOOZ N/A
- Average True Range (ATR)
- EVAX 0.13
- ZOOZ 0.00
- MACD
- EVAX 0.03
- ZOOZ 0.00
- Stochastic Oscillator
- EVAX 59.18
- ZOOZ 0.00
About EVAX Evaxion Biotech
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.
About ZOOZ ZOOZ POWER LTD
Zooz Power Ltd is a provider of Flywheel-based Power Boosting solutions enabling widespread deployment of ultra-fast charging infrastructure for electric vehicles (EV) while overcoming existing grid limitations. ZOOZ pioneers its flywheel-based power boosting technology, enabling efficient utilization and power management of a power-limited grid at an EV charging site. Its Flywheel technology allows high-performance, reliable, and cost-effective ultra-fast charging infrastructure. ZOOZ Power's sustainable, power-boosting solutions are built with longevity and the environment in mind, helping its customers and partners accelerate the deployment of fast-charging infrastructure, thus facilitating improved utilization rates, efficiency and greater flexibility.